Prevalence of Bacteria in the Circulation of Cardiovascular Disease Patients, Madurai, India

Heart Lung and Circulation

Volumn 21, Issue 5, 2012, Pages 281-283

  Dinakaran, Vasudevan ^a   John, Leishman ^a   Rathinavel, Andiappan ^b   Gunasekaran, Paramasamy ^a   Rajendhran, Jeyaprakash ^a  

^a MADURAI KAMARAJ UNIVERSITY   (India)

^b MADURAI MEDICAL COLLEGE   (India)

Author keywords

16S rRNA; Bacteraemia; Cardiovascular diseases; Circulation; Staphylococci

Indexed keywords

RNA 16S;

ACINETOBACTER; AEROCOCCUS VIRIDANS; ARTICLE; BACILLACEAE; BACILLUS CEREUS; BACTEREMIA; BACTERIAL GROWTH; BACTERIUM; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BIOCHEMICAL EQUIPMENT; BLOOD CULTURE; BLOOD SAMPLING; BRACHYBACTERIUM; BREVIBACILLUS; BREVIBACTERIUM; CAMPYLOBACTER GRACILIS; CARDIOVASCULAR DISEASE; CELLULOMONAS; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONGENITAL HEART DISEASE; CORYNEBACTERIUM; CORYNEBACTERIUM CASEI; CORYNEBACTERIUM MUCIFACIENS; DIETZIA CF MARIS; EXIGUOBACTERIUM; FUSOBACTERIUM NUCLEATUM; HUMAN; INDIA; INTRASPORANGIUM CALVUM; ISCHEMIC HEART DISEASE; JANIBACTER MELONIS; KOCURIA; KOCURIA PALUSTRIS; MICROBACTERIUM; MICROBACTERIUM AURUM; MICROBACTERIUM PARAOXYDANS; MICROCOCCUS LUTEUS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PEPTOSTREPTOCOCCUS; PREVALENCE; PRIORITY JOURNAL; PROPIONIBACTERIACEAE; PSEUDOMONAS; SEQUENCE ANALYSIS; SERINICOCCUS; SPECIES IDENTIFICATION; SPHINGOBACTERIUM; STAPHYLOCOCCUS; STAPHYLOCOCCUS ARLETTAE; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS EQUORUM; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; STAPHYLOCOCCUS PASTEURI; STREPTOCOCCUS AGALACTIAE; VALVULAR HEART DISEASE;

BACTEREMIA; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; HUMANS; INDIA; INFLAMMATION; PREVALENCE; RISK FACTORS;

EID: 84861200389     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2012.02.007     Document Type: Article

References (11)

1. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease: is there a link?. Lancet 1997, 350:430-436.
2. O'Connor S., Taylor C., Campbell L.A., Epstein S., Libby P. Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerg Infect Dis 2001, 7:5.
3. Zhu J., Nieto F.J., Horne B.D., Anderson J.L., Muhlestein J.B., Epstein S.E. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001, 103:45-51.
4. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
5. Wang Y., Qian P.Y. Conservative fragments in bacterial 16S rRNA genes and primer design for 16S ribosomal DNA amplicons in metagenomic studies. PLoS One 2009, 4:10.
6. Ott S.J., Mokhtari N.E., Musfeldt M., Hellmig S., Freitag S., Rehman A., et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 2006, 113:929-937.
7. Muñoz P., Bouza E., Marín M., Alcalá L., Rodríguez Créixems M., Valerio M., et al. Heart valves should not be routinely cultured. J Clin Microbiol 2008, 46:2897-2901.
8. Chu V.H., Woods C.W., Miro J.M., Hoen B., Cabell C.H., Pappas P.A., et al. Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis 2008, 46:232-242.
9. Rothenbacher D., Brenner H., Hoffmeister A., Mertens T., Persson K., Koenig W. Relationship between infectious burden, systemic inflammatory response, and risk of stable coronary artery disease: role of confounding and reference group. Atherosclerosis 2003, 170:339-345.
10. Sessa R., Nicoletti M., Di Pietro M., Schiavoni G., Santino I., Zagaglia C., et al. Chlamydia pneumoniae and atherosclerosis: current state and future prospectives. Int J Immunopathol Pharmacol 2009, 22:9-14.
11. Fournier P.E., Thuny F., Richet H., Lepidi H., Casalta J.P., Arzouni J.P., et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis 2010, 51:131-140.